Day One Biopharmaceuticals, Inc. ( DAWN) - Key Metrics
Stock symbol DAWN is outdated, potentially delisted? Maybe it is available on other exchange?
DAWN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.52 | -$0.21 | -$0.14 | -$0.17 |
| 2025Q3 | $0.38 | -$0.19 | -$0.06 | -$0.06 |
| 2025Q2 | $0.33 | -$0.29 | -$0.24 | -$0.21 |
| 2025Q1 | $0.30 | -$0.35 | -$0.57 | -$0.61 |
| 2024Q4 | $0.31 | -$0.70 | -$0.32 | -$0.34 |
DAWN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -11.32 |
| 2025Q3 | ? | -9.24 |
| 2025Q2 | ? | -5.52 |
| 2025Q1 | ? | -5.66 |
| 2024Q4 | ? | -4.51 |
DAWN
Price: $21.53
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 433900
Market Capitalization: 2.2 billion